Jakavi (ruxolintib)

pCPA File Number: 21948
Negotiation Status:
Concluded with an LOI
Indication(s):
chronic graft-versus-host disease
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CADTH Project Number:
SR0706
pCPA Engagement Letter Issued:
Negotiation Process Concluded: